Glanbia plc GLAPF
21.08 USD 0.00 (+0.00%)
At closeNov 11, 2026, 4:00 PM EST
24.50 Day range 24.70
15.99 52-week range 28.81
- YTD
- +24.00%
- 1 year
- +25.48%
News
seekingalpha.com Longleaf Partners Global Fund Q3 2026 Portfolio Review Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. In the first part of the year before we invested,…
defenseworld.net Glanbia plc (OTCMKTS:GLAPF) Sees Large Increase in Short Interest Glanbia plc (OTCMKTS:GLAPF - Get Free Report) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totaling 183,065…
defenseworld.net Glanbia (OTCMKTS:GLAPF) Share Price Crosses Below 200-Day Moving Average – Time to Sell? Shares of Glanbia plc (OTCMKTS:GLAPF - Get Free Report) crossed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $24.40 and traded…
defenseworld.net Glanbia (OTCMKTS:GLAPF) Share Price Crosses Above 200 Day Moving Average – Here’s Why Glanbia plc (OTCMKTS:GLAPF - Get Free Report) shares passed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $23.33 and traded as high as $25.8980.…
reuters.com Glanbia hikes profit forecast as weight-loss drugs boost demand for protein products Nutrition supplement maker Glanbia hiked its full-year profit forecast on Thursday following bumper demand for its protein products, including from customers using them in tandem with weight-loss…
benzinga.com Stocks That Hit 52-Week Lows On Friday